Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
abolished, aggravating, anemia, banker, baseline, beneficiary, burden, Canada, chronic, CMML, cord, counterparty, creation, cybersecurity, dissemination, dollar, esophageal, exhibited, expedient, faster, gamma, hindsight, HIPPAA, implicit, implicitly, inactive, inflationary, insignificant, IRA, kappa, legacy, lessening, Leukocyte, lymphopenia, mAb, matching, monetize, MSD, myelodyplastic, myelodysplastic, myelomonocytic, nM, ourself, persistence, posture, reconstituted, relapse, residual, ROU, Russia, syndrome, transplanted, twelve, Ukraine, wind, withstanding, worsening
Removed:
acid, acted, adenocarcinoma, AG, alternate, amylase, arrive, AstraZeneca, asymptomatic, biopsy, call, constrained, constraint, cumulative, defining, diarrhea, differentiation, distinguish, diverse, dosed, easily, engineered, exceeded, fatigue, fatty, Fenner, freely, GlaxoSmithKline, half, highest, HNSCC, Institute, Jaffray, licensee, lipase, localized, Lynch, mammalian, manageable, maximal, median, Merkel, Merrill, mild, misdirected, mm, moderate, modulator, Morgan, OPM, outbreak, outlined, outset, overwhelmed, Pfizer, Pierce, Piper, plc, point, predominant, proliferation, promised, reached, regulating, remained, rental, reserve, Roche, route, Sanofi, signal, SITC, Smith, Society, Squibb, standalone, Stanley, steroid, stimulation, sublandlord, sublease, subleasing, sugar, suppressive, TNBC, TNF, tradable, transferring, treated, unconditional, unidentified, vitiligo
Filing tables
Filing exhibits
Related press release
NXTC similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
(1) | Registration Statement (Form S-8 No. 333-231438) pertaining to the NextCure, Inc. 2019 Employee Stock Purchase Plan, |
(2) | Registration Statement (Form S-8 No. 333-231436) pertaining to the NextCure, Inc. 2015 Omnibus Incentive Plan and the NextCure, Inc. 2019 Omnibus Incentive Plan, |
(3) | Registration Statement (Form S-8 No. 333-260776) pertaining to the NextCure, Inc. 2019 Employee Stock Purchase Plan, |
(4) | Registration Statement (Form S-8 No. 333-260779) pertaining to the NextCure, Inc. 2019 Omnibus Incentive Plan, and |
(5) | Registration Statement (Form S-3 No. 333-241706) of NextCure, Inc.; |
of our report dated March 2, 2023, with respect to the financial statements of NextCure, Inc. included in this Annual Report (Form 10-K) of NextCure, Inc. for the year ended December 31, 2022.
| |
/s/ Ernst & Young LLP | |
| |
Baltimore, Maryland | |
March 2, 2023 | |